scholarly journals In Vitro Evaluation of Cholesterol-Reducing Ability of Chitosan from Mangrove Crab (Scylla serrata) Shell Solid Dispersion using PVP K-30 as a Carrier

Author(s):  
Hilya Nur Imtihani ◽  
Silfiana Nisa Permatasari ◽  
Rahmad Aji Prasetya

Background: Chitosan is a compound that can be synthesized from nature which can reduce the total serum cholesterol levels between 5.8−42.6% and decrease LDL (Low-Density Lipoprotein) between 15.1-35.1%. One of the natural resources containing chitosan derivative compounds is the shell of mud crab. Chitosan is insoluble in water but soluble in acidic solutions such as acetic acid. With such chitosan solubility, it is necessary to increase the solubility by making a solid dispersion system so that drug absorption can be faster. Objectives: The aims of this study is to determine the potential of chitosan solid dispersion system for reducing cholesterol. Material and Methods: The reduction of cholesterol levels was carried out by in vitro tests using UV-Vis spectrophotometer at a wavelength of 405 nm with Lieberman-Burchad reagent. The positive control used was simvastatin. There are 4 formulas, namely SD1, PM1, SD2, and PM2. This solid dispersion system uses polyvinyl pyrrolidone K-30 (PVP K-30) as carrier. Results: The characterization of chitosan has fulfilled all the characterization requirements that is organoleptic (shape and color) was creamy white, moisture content was 2.15%, ash content was 1.14%, ninhydrin test was positive purple, and deacetylation degree was 70.57%. The results of in vitro evaluation were obtained a dark green solution. The reducing percentage in cholesterol levels are SD1: 18.44%; PM1 : 18.11%; SD2 : 29.57%; and PM2 :12.01%. Simvastatin as a positive control has a percentage reduction in cholesterol levels of 30.07%.  Conclusion: Chitosan has an activity as anticholesterol agent. SD2 (Solid Dispersion Chitosan: PVP K-30 = 1:2) has the higher percentage than other formulas for reducing cholesterol level comparable with the positive control.

1996 ◽  
Vol 44 (12) ◽  
pp. 2309-2313 ◽  
Author(s):  
Katsuhiko YANO ◽  
Atsushi KAJIYAMA ◽  
Shigeru YAMAZAKI ◽  
Yoshisuke MATSUMURA ◽  
Kouji WATANABE ◽  
...  

Author(s):  
Erizal Zaini ◽  
Salman Umar ◽  
Nurhidayah Nurhidayah

ABSTRACTObjective: To improve dissolution rate of valsartan from solid dispersion system of valsartan and D(−) mannitol using co-grinding approach.Methods: Valsartan solid dispersion with different ratio of D(−) mannitol (1:1; 1:3 and 1: 5) were prepared by co-grinding method. Solid statecharacterization of the solid dispersion system was evaluated in term of crystallographic properties (powder X-ray diffraction), thermal behavior(differential scanning calorimetry [DSC]) and morphology (scanning electron microscope). The profile of dissolution rate was examined using USPdissolution apparatus type I at a temperature of 37±0.5°C.Results: Based on thermal analysis DSC and powder X-ray diffraction analysis, valsartan was transformed from semicrystalline phase to amorphousstate as indicated by the disappearance of its melting endothermic peaks and the characteristic diffraction peaks. The in vitro dissolution rate studyrevealed that all solid dispersion system showed significant increase in dissolution rate compared with the intact valsartan.Conclusion: Solid dispersion of valsartan with D(−) mannitol prepared by co-grinding technique has successfully improved the dissolution ratecompared with intact valsartan.Keywords: Valsartan, D(−) mannitol, Solid dispersion, Co-grinding, Dissolution rate.


Sign in / Sign up

Export Citation Format

Share Document